Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2007
03/22/2007US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor
03/22/2007US20070066565 Cyclic maltosylmatose
03/22/2007US20070066557 Modulation of glucocorticoid receptor expression
03/22/2007US20070066556 Antisense antiviral compound and method for treating picornavirus infection
03/22/2007US20070066555 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
03/22/2007US20070066554 Immunostimulatory nucleic acids
03/22/2007US20070066553 Immunostimulatory nucleic acid molecules
03/22/2007US20070066550 Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics
03/22/2007US20070066549 Modified antisense oligonucleotide; antitumor and anticancer agents
03/22/2007US20070066547 Ligands
03/22/2007US20070066538 Treatment of wounds
03/22/2007US20070066535 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation
03/22/2007US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
03/22/2007US20070066520 Novel epidermal growth factor protein and gene, and methods of use therefor
03/22/2007US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells
03/22/2007US20070065931 use in modulation of gene expression in plant cells; use in optimizing crop traits such as nutritional value, disease resistance, herbicide resistance; agronomics
03/22/2007US20070065928 DNA, nucleaotides sequences and polynucleotides that code for sugar metabolism and oxidative phosphorylation proteins; genetic engineered microorganisms used for biosynthesis of amino acids
03/22/2007US20070065926 Circular site-directed mutagenesis
03/22/2007US20070065925 Vaccine containing cell transformed with a nucleotide sequence of the genome of Porcine circovirus type B
03/22/2007US20070065920 For treatment of microbial conditions (including malaria), proliferative disorders, inappropiate vascularisation, inhibition of angiogenesis;
03/22/2007US20070065915 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals
03/22/2007US20070065914 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
03/22/2007US20070065913 Isolation of binding proteins with high affinity to ligands
03/22/2007US20070065912 Multiple Gene Expression including sORF Constructs and Methods with Polyproteins, Pro-Proteins, and Proteolysis
03/22/2007US20070065910 bacterium or yeast cells genetically engineered to express mutated chorismate mutase/prephenate dehydrogenase, used in the production of tyrosine-enriched foods or nutraceuticals
03/22/2007US20070065909 Prokaryotically produced antibodies and uses thereof
03/22/2007US20070065906 Process for producing heterologous protein in e. coli
03/22/2007US20070065905 Process for expression and secretion of proteins by the non-conventional yeast zygosaccharomyces bailii
03/22/2007US20070065904 Recombinant expression vectors for functional nav1.9 sodium channels
03/22/2007US20070065903 Process for chromosomal expression of foreign genes in the hsdM region of a methylotrophic microbial host cell
03/22/2007US20070065902 Process for chromosomal expression of foreign genes in the fliC region of a methylotrophic microbial host cell
03/22/2007US20070065901 Process for chromosomal expression of foreign genes in the PAPS reductase (cysH) region of a methylotrophic microbial host cell
03/22/2007US20070065900 Process for chromosomal expression of foreign genes in the cytochrome-C peroxidase (cytCP) region of a methylotrophic microbial host cell
03/22/2007US20070065895 Substrates specific to von willebrand factor cleaving protease and method of assaying the activity
03/22/2007US20070065892 High throughput assay of lp-pla2 activity
03/22/2007US20070065883 Molecules that modulate Galphaq activity and methods of treating urinary incontinence
03/22/2007US20070065876 Marking
03/22/2007US20070065875 NTB-A, a surface molecule involved in natural killer cells activity
03/22/2007US20070065873 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators
03/22/2007US20070065871 Human T2R71 receptor and related assays for identifying human bitter taste modulators
03/22/2007US20070065870 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste
03/22/2007US20070065869 Methods for producing ligand arrays
03/22/2007US20070065868 IL-17 receptor like molecules and uses thereof
03/22/2007US20070065867 Promoter and plasmid system for genetic engineering
03/22/2007US20070065849 Nucleic acid encoding eosinophil eotaxin receptor
03/22/2007US20070065846 Gene expression profiling in biopsied tumor tissues
03/22/2007US20070065845 Gene expression profiling in biopsied tumor tissues
03/22/2007US20070065838 Oligonucleotide mediated nucleic acid recombination
03/22/2007US20070065829 In vitro differentiation of vascular smooth muscle cells, methods and reagents related thereto
03/22/2007US20070065828 Oligonucleotide for genotyping of mycoplasma, microarray comprising the oligonucleotide, and method for detection of species using the microarray
03/22/2007US20070065823 Method and compositions for detection and enumeration of genetic variations
03/22/2007US20070065817 Nucleic acid probes for detection of non-viral organisms
03/22/2007US20070065467 Immunostimulatory nucleic acid molecules for activating dendritic cells
03/22/2007US20070065466 Clostridium difficile vaccine
03/22/2007US20070065465 Conjugate vaccines for the prevention of dental caries
03/22/2007US20070065455 relates to osteopontin (Eta-1) polypeptides ; for enhancing an immune response in an animal; for therapy and prophylaxis of infectious diseases or cancer; immunization
03/22/2007US20070065454 Liposomal vaccine
03/22/2007US20070065453 Transferrin-binding proteins from neisseria gonorrhoeae and neisseria meningitidis
03/22/2007US20070065448 Methods and compositions for treating diseases targeting MABA1
03/22/2007US20070065445 Novel cyclooxygenase variants and methods of use
03/22/2007US20070065440 Antibody compositions and methods
03/22/2007US20070065435 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics
03/22/2007US20070065434 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics
03/22/2007US20070065432 Antibody fragment-targeted immunoliposomes for systemic gene delivery
03/22/2007US20070065431 A polynucleotide encoding a monomeric non-antibody ligand having a loop partly modified or replaced by or amino acid(s); improved solubility; medical diagnosis; targets of drugs, steroids, pesticides, antigens, growth factors, tumour markers, cell surface proteins or viral coat proteins
03/22/2007US20070065427 Agents that modulate immune cell activation and methods of use thereof
03/22/2007US20070065424 Rationally designed polysaccharide lyases derived from chondroitinase B
03/22/2007US20070065412 Production of recombinant AAV using adenovirus comprising AAV rep/cap genes
03/22/2007US20070065410 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents
03/22/2007US20070065409 Use of pleiotrophin in the diagnosis, treatment and prevention of disease
03/22/2007US20070065408 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b
03/22/2007US20070065407 Interferon-Alpha Polypeptides and Conjugates
03/22/2007DE102006033911A1 New nucleic acid containing the kirromycin biosynthesis gene cluster, useful for preparing the antibacterial kirrimycin and its derivatives or fragments
03/22/2007DE102005044736A1 Neue Dehydrogenasen, deren Derivate und ein Verfahren zur Herstellung von optisch aktiven Alkanolen New dehydrogenases, their derivatives and to a process for preparing optically active alkanols
03/22/2007DE102005043979A1 Verfahren zur Produktion von Aminosäuren in aminosäureproduzierenden Mikroorganismen A process for the production of amino acids in amino acid-producing microorganisms
03/22/2007DE102005043669A1 Verfahren zur enzymatischen Synthese von Ethern A method for the enzymatic synthesis of ethers
03/22/2007DE10024132B4 Anordnung zur Detektion von Fluoreszenzlicht mehrerer Probenpunkte Arrangement for detection of fluorescence light of several sample points
03/22/2007CA2820201A1 Identification of tumor-associated antigens for diagnosis and therapy
03/22/2007CA2622761A1 Modulation of immunostimulatory properties of short interfering ribonucleic acid (sirna) by nucleotide modification
03/22/2007CA2622610A1 Fish vaccine
03/22/2007CA2622583A1 Rna antagonist compounds for the inhibition of apo-b100 expression
03/22/2007CA2622440A1 Molecular method for diagnosis of prostate cancer
03/22/2007CA2622295A1 Recurrent gene fusions in prostate cancer
03/22/2007CA2622242A1 Inhibition of viral gene expression using small interfering rna
03/22/2007CA2621489A1 Plant yield improvement by group 3 lea expression
03/22/2007CA2621422A1 Esterase gene and use thereof
03/22/2007CA2621407A1 Alcohol acetyl transferase gene and use thereof
03/22/2007CA2621363A1 Methods and compositions for modulating tumor cell activity
03/22/2007CA2621344A1 Cleavage of precursors of insulins by a variant of trypsin
03/22/2007CA2621248A1 Anti-human sr-b1 antibody reducing inflammation and treating auto-immunedisease
03/22/2007CA2621243A1 Plant viral particles comprising a plurality of fusion proteins consisting of a plant viral coat protein, a peptide linker and a recombinant protein and use of such plant viral particles for protein purification
03/22/2007CA2620881A1 Method for the selective enrichment of double-stranded dna from nucleic acid mixtures
03/22/2007CA2620872A1 A new selection system for wheat
03/22/2007CA2619657A1 Transplastomic plants expressing lumen-targeted protein
03/22/2007CA2619615A1 Method for determination of effective dose of methotrexate
03/22/2007CA2619298A1 Modified antigen binding molecules with altered cell signaling activity
03/22/2007CA2619139A1 Cell-based microarrays and methods of use
03/22/2007CA2618429A1 A hepatitis c virus non-structural ns3/4a fusion gene
03/22/2007CA2611028A1 Genetically modified yeast of the species issatchenkia orientalis and closely related species and fermentation processes using same
03/21/2007EP1764421A2 Device for decarbonising a steel melt
1 ... 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 ... 4023